Sessions
This page was updated on August 19th 2025.
ETRS 2025 Sessions
Each session consists of one session keynote by an invited speaker, guest speakers and a number of oral presentations selected from abstracts.
Charles Lapière Memorial Lecture
WED 03/09 | 16.00 – 17.00
Honorary Lecture by Dame Professor Molly Stephens
Oxford University, UK
New bioengineering-based approaches for therapeutics and biosensing in tissue repair
SESSION 1 | 3D-Printing, Biomaterials & Bioengineering
WED 03/09 | 10.15 – 12.30
Session Keynote by Professor Liam Grover
University of Birmingham, UK
Modifying Healing Using Soft Matter
Guest Speaker
Dr. Oommen Oommen
SMART HYALURONAN HYDROGELS FOR INDUCING PRO-HEALING MACROPHAGE RESPONSES AND NEURONAL REGENERATION.
Abstracts
Dr Oommen Varghese, Uppsala University, Sweden
O1. Engineering Hyaluronic Acid-Based Bioink for Ultra-Fine 3D Bioprinting to Develop in Vitro Models.
Saskia Fogg, University of Birmingham, UK
O2. Support Matrix Influences on Printing Resolution in a 3D Bioprinted Human Skin Model.
Mahrukh Riaz, University of Zurich, Switzerland
O3. Human Skin Substitute With Restored Innervation, Vasculature, and Hair Follicles for Full-Thickness Wound Treatment.
Dr Elise Krawiec, University of Reims Champagne-Ardenne, France
O4. Adjusting the Handling of a Cell Free Hydrogel System Based on Wharton’s Jelly Extracellular Matrix to Optimise Facial Nerve Regeneration.
SESSION 2 | Stem Cells & Regenerative Medicine
WED 03/09 | 13.30 – 15.45
Session Keynote by Professor Paul Genever
University of York, UK
MESENCHYMAL STROMAL CELLS: REPAIRING TISSUES AND REPUTATIONS
Guest Speaker
Dr. Laura Howard
ENGINEERING EYE-LIKE ORGANOIDS AND TISSUES FROM HUMAN IPS CELLS: APPLICATIONS FOR REGENERATIVE MEDICINE.
Abstracts
Dr Mariah Lelos, Cardiff University, UK
O5. Generation of a Stem Cell-Derived Cell Therapy Product for Huntington’s Disease.
Prof. Yuji Teramura, National Institute of Advanced Industrial Science and Technology, Japan
O6. Corneal Epithelial Wound Healing by Purified Components from Immortalized Stem Cells From Human Exfoliated Deciduous Teeth.
Joanne Chang, Royal College of Surgeons in Ireland, Ireland
O7. Development of Extracellular Matrix Protein-Decorated Hydrogels for Vascularisation.
SESSION 3 | Infection, Inflammation & Wound Healing
THU 04/09 | 08.30 – 10.05
Session Talk by Dr. Jenna Cash
University of Edinburgh, UK
Derailed Cellular Choreography in the Skin Ulcer Niche: Roadblocks to Repair.
Abstracts
Dr Marta Torregrossa, Leipzig University, Germany
O8. Iron-Induced Changes in Dermal Fat-Fibroblast-Signalling Axis Drive Disease progression in Lipodermatosclerosis.
Dr Petra Döerfler, Akribes Biomedical, Austria
O9. Identification and Charactierization of AKR101 as Potential New Therapeutic for Chronic Wounds.
Dr Tom Prescott, Royal Botanical Gardens Kew, UK
O10. A Clinical Trial Examining Ficus Septica Latex for the Treatment of Small Cutaneous Ulcers in Papua New Guinea.
SESSION 4 | Scarring & Wound Regeneration
THU 04/09 | 10.30 – 12.30
Session Keynote by Dr. Claire Higgins
Imperial College London, UK
EXPLOITING THE HAIR FOLLICLE TO PROMOTE SKIN HEALING AND REMODEL SCAR TISSUE
Guest Speaker
Dr. Soma Meran
CAN WE MODIFY HYALURONAN MATRIX TO PROMOTE RENAL RECOVERY AFTER INJURY?
Abstracts
Dr Oscar Peña Cabello, University of Bristol, UK
O11. A Novel Population Health-Based Pipeline to Screen for Scarring Genes Reveals a Role for LGR4 in Skin Repair.
Prof. Andrew Leask, University of Saskatchewan, Canada
O12. CCN3-Based Peptide BLR-200 Has Anti-Fibrotic Properties in Systemic Sclerosis.
Dr Xanthe Venn, University of South Australia, Australia
O13: Development of a Flightless I Neutralising Antibody Therapy for the Treatment of Burns.
SESSION 5 | Drug Development for Wound Healing – QBiotics Symposium
THU 04/09 | 13.30 – 15.20
Session Talk by Dr. Paul Reddell
QBiotics Group, Australia
Session Talk by Prof. David Thomas – THE APPLICATION OF THE EPOXYTIGLIANE, EBC-1013, IN THE TREATMENT OF INFECTED WOUNDS: DEFINING THE ORTHOGONAL MECHANISMS OF ACTION
Cardiff University, UK
Session Talk by Dr. Jason Cullen – INVESTIGATING EPOXYTIGLIANE-MEDIATED IMMUNOMODULATORY PROCESSES IN THE CONTEXT OF CHRONIC WOUND HEALING
QBiotics Group, Australia
Session Talk by Dr. Emma Woods – CHRONIC WOUND FIBROBLAST RESPONSIVENESS TO EPOXYTIGLIANE-STIMULATED REPAIR MECHANISMS IS DEPENDENT ON FIBROBLAST KINOME PROFILES
QBiotics Group, Australia
Session Talk by Prof. Ryan Moseley – EPOXYTIGLIANE STIMULATION OF KERATINOCYTE WOUND HEALING RESPONSES PROMOTE ENHANCED SKIN RE-EPITHELIALISATION
Cardiff University, UK
Session Talk by Prof. Keith Harding – WOUNDS IN CARDIFF: 20 YEARS ON
Cardiff University, UK
SESSION 6 | ETRS Young Investigator Award
THU 05/09 | 15.45 – 18.00
Selected talks by ETRS Young Investigator Awardees + Invited Lectures by WHS Young Investigator Award Winner 2025 and WHS Mid-career Researchers
Jonathan Kessler, Leipzig University, Germany
Y1. Understanding Confined Functions of Neutrophils in the Pathophysiology of Diabetic Wound Healing.
Yongfang Wang, Ulm University, Germany
Y2. Synergism of Endothelial Cell Death and Fibroblast Senescence in Diabetic Angiopathy.
Terrance Trinca, University of Bristol, UK
Y3. Identifying Novel Wound Extravasation Genes Using a Drosophila-to-Murine Pipeline.
Anna Buisan-Farre, Central University of Catalonia, Spain
Y4. Proteomic Profiling of Platelet-Rich Plasma to Predict Therapy Outcomes in Complex Wounds.
Jessica Da Silva, University of Coimbra, Portugal
Y5. Alginate-Based Hydrogels Loaded With Human Βeta-Defensin-2 Enhance Healing of Infected and Non-Infected Wounds in a Diabetic Mouse Model.
Fabian Stritt, University Hospital Erlangen, Germany
Y6. The Immunomodulator Soluble CD83 Ameliorates Wound Healing Quality in a Murine Pressure Ulcer Mode by Inducing Tissue Repair Macrophages.
Dr Suwelack Corporate Foundation Head of Consortium Speech. Professor Adrian Dragu.
Dr Suwelack Corporate Foundation Young Investigator Award Winner: Effect of Hyaluronan in Collagen Biomaterials on Human Macrophages and Fibroblasts In Vitro. Nancy Avila-Martinez, Radboud University Medical Centre, The Netherlands
WHS YIA Winner 2025 – Veronika Jurczuk, University of Miami, USA
Statin-Cyclodextrin Hydrogels Accelerate Healing In Multiple Pre-Clinical Wound Models.
WHS Mid-Career Researcher 1 – Dr Kanhaiya Singh, University of Pittsburgh, USA
Endothelial Metallothionein is Epigenetically Regulated and Indispensable for Diabetic Ischemic Tissue Rescue Following VEGF Therapy.
WHS Mid-Career Researcher 2 – Dr Swathi Balaji, Baylor College of Medicine, USA
Role of Fibroblast Energy Metabolism and Exosome Signalling in Regulating Wound Healing and Fibrosis.
SESSION 7 | Wound Healing Therapy Translation, Regulation & Public Perception (Workshop)
FRI 05/09 | 08.30 – 10.35
Session Talks by Dr Paul Reddell, Dr Paul Genever, Dr Alan Horner, Dr Lindsey Davies, Dr Maki Umemura
QBiotics Group, Australia; University of York, UK; Convatec Wound Care, UK; NextCell Pharma, Sweden; Cardiff University, UK
Paul Reddell: Background & Introduction to the workshop.
Paul Genever: University Spin-Out of Biomedical Research – From Academia to SME.
Alan Horner: What does medtech look for in terms of the development and commercialisation of new wound healing therapies?
Lindsay Davies: Regulatory considerations surrounding regenerative medicine therapy translation and commercialisation.
Maki Umemura: Shifting Perceptions: Comparative perspectives on Regenerative Medicine Development.
SESSION 8 | Matrix Modulation of Tissue Repair
FRI 05/09 | 11.00 – 12.55
Session Keynote by Professor Tero Järvinen
Tampere University, FINLAND
Systemically administered, target-specific therapies for tissue repair.
Guest Speaker
Prof. Denis Barritault, OTR3, France
ARE HEPARAN SULFATES THE LEAD TO REACH THE GRAIL OF TISSUE REGENERATION?
Guest Speaker
Prof. Susan Volk, University of Pennsylvania, USA
TYPE III COLLAGEN: MODULATOR OF BIOCHEMICAL, BIOMECHANICAL, AND BIOPHYSICAL DYNAMICS IN TISSUE REPAIR
SESSION 9 | Exploiting Biologics for Enhanced Healing
FRI 05/09 | 13.30 – 15.30
Session Keynote by Dr Ning Xu Landen
Karolinska Institute, SWEDEN
Decoding the RNA regulome of human skin wound healing – Towards future wound care.
Guest Speaker
Prof. Tim Bowen, Cardiff University, UK
MICRORNAs AS DISEASE SENTINELS AND THERAPEUTIC TARGETS IN PATIENTS WITH KIDNEY DISEASE.
Abstracts
Dr Piul Rabbani, New York University School of Medicine, USA
O15. Topical Exosomes Mediate Wound Healing Benefit Via Modulation of Innate Immune Cellular Milieu.
Dr Ermelindo Leal, University of Coimbra, Portugal
O16. Targeting PTP1B Enhances Diabetic Wound Healing by Modulating Macrophage Polarization Via HO-1 Pathway.
Phillipp Beck, University Hospital Erlangen, Germany
O17. Soluble CD83 Enhances Intestinal Wound Healing in DSS-Induced Colitis.